Achieve Life Sciences, Inc. Increase (Decrease) in Accounts Receivable
Achieve Life Sciences, Inc. (ACHV) reported Increase (Decrease) in Accounts Receivable of -$8.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2021-08-12
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-09-30 was $0.00.
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-06-30 was $0.00.
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2020-03-31 was -$8.00K.
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for the quarter ending 2018-12-31 was -$18.00K.
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for fiscal 2019 was $1.00K.
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for fiscal 2018 was -$2.00K, a 122.22% decline from fiscal 2017.
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for fiscal 2017 was $9.00K, a 98.06% decline from fiscal 2016.
- Achieve Life Sciences, Inc. increase (decrease) in accounts receivable for fiscal 2016 was $464.00K.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 3 month as first filed | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 6 month as first filed | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 9 month as first filed | Increase (Decrease) in Accounts Receivable 12 month | Increase (Decrease) in Accounts Receivable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2021-08-12 | -$8.00K 10-Q · filed 2020-11-12 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$8.00K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | -$8.00K 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | $1.00K 10-K · filed 2020-03-13 | |||||||
| 2018-12-31 | -$18.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | -$23.00K derived: sum of 2 quarters · filed 2020-03-13 | -$2.00K 10-K · filed 2020-03-13 | |||||
| 2018-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $16.00K 10-Q · filed 2019-11-06 | ||||||
| 2018-06-30 | $21.00K 10-Q · filed 2019-08-08 | |||||||
| 2017-12-31 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $246.00K derived: sum of 2 quarters · filed 2020-03-13 | $250.00K derived: sum of 3 quarters · filed 2020-03-13 | $9.00K 10-K · filed 2020-03-13 | ||||
| 2017-09-30 | $401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $405.00K derived: sum of 2 quarters · filed 2018-11-07 | $164.00K 10-Q · filed 2018-11-07 | $484.00K derived: sum of 4 quarters · filed 2018-11-07 | ||||
| 2017-06-30 | $4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | -$237.00K 10-Q · filed 2017-07-31 | $83.00K derived: sum of 3 quarters · filed 2017-07-31 | -$66.00K derived: sum of 4 quarters · filed 2017-07-31 | ||||
| 2017-03-31 | -$241.00K 10-Q · filed 2017-05-15 | $79.00K derived: sum of 2 quarters · filed 2017-05-15 | -$70.00K derived: sum of 3 quarters · filed 2017-05-15 | $4.00K derived: sum of 4 quarters · filed 2017-07-31 | ||||
| 2016-12-31 | $320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $171.00K derived: sum of 2 quarters · filed 2017-02-23 | $245.00K derived: sum of 3 quarters · filed 2017-07-31 | $464.00K 10-K · filed 2017-02-23 | ||||
| 2016-09-30 | -$149.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$75.00K derived: sum of 2 quarters · filed 2017-07-31 | $144.00K 10-Q · filed 2016-11-10 | $145.00K derived: sum of 4 quarters · filed 2017-07-31 | ||||
| 2016-06-30 | $74.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-31 | $293.00K 10-Q · filed 2017-07-31 | $294.00K derived: sum of 3 quarters · filed 2017-07-31 | $158.00K derived: sum of 4 quarters · filed 2017-07-31 | ||||
| 2016-03-31 | $219.00K 10-Q · filed 2017-05-15 | $220.00K derived: sum of 2 quarters · filed 2017-05-15 | $84.00K derived: sum of 3 quarters · filed 2017-05-15 | -$1.33M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$135.00K derived: sum of 2 quarters · filed 2017-02-23 | -$1.54M derived: sum of 3 quarters · filed 2017-02-23 | -$5.66M 10-K · filed 2017-02-23 | ||||
| 2015-09-30 | -$136.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$1.55M derived: sum of 2 quarters · filed 2016-11-10 | -$5.66M 10-Q · filed 2016-11-10 | -$4.81M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-30 | -$1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$5.53M 10-Q · filed 2016-08-04 | -$4.68M derived: sum of 3 quarters · filed 2017-02-23 | -$4.80M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-31 | -$4.12M 10-Q · filed 2016-05-12 | -$3.27M derived: sum of 2 quarters · filed 2017-02-23 | -$3.39M derived: sum of 3 quarters · filed 2017-02-23 | -$7.05M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $849.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $725.00K derived: sum of 2 quarters · filed 2017-02-23 | -$2.93M derived: sum of 3 quarters · filed 2017-02-23 | -$2.98M 10-K · filed 2017-02-23 | ||||
| 2014-09-30 | -$124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | -$3.78M derived: sum of 2 quarters · filed 2015-11-12 | -$3.83M 10-Q · filed 2015-11-12 | -$5.09M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-06-30 | -$3.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$3.71M 10-Q · filed 2015-08-13 | -$4.97M derived: sum of 3 quarters · filed 2016-03-09 | -$1.49M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2014-03-31 | -$47.00K 10-Q · filed 2015-05-14 | -$1.31M derived: sum of 2 quarters · filed 2016-03-09 | $2.17M derived: sum of 3 quarters · filed 2016-03-09 | $3.45M derived: sum of 4 quarters · filed 2016-03-09 | ||||
| 2013-12-31 | -$1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-09 | $2.22M derived: sum of 2 quarters · filed 2016-03-09 | $3.50M derived: sum of 3 quarters · filed 2016-03-09 | $7.94M 10-K · filed 2016-03-09 | ||||
| 2013-09-30 | $3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-30 | $4.77M derived: sum of 2 quarters · filed 2014-10-30 | $9.21M 10-Q · filed 2014-10-30 | $9.29M derived: sum of 4 quarters · filed 2015-03-26 | ||||
| 2013-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $5.72M 10-Q · filed 2014-08-07 | $5.81M derived: sum of 3 quarters · filed 2015-03-26 | $5.96M derived: sum of 4 quarters · filed 2015-03-26 | ||||
| 2013-03-31 | $4.44M 10-Q · filed 2014-04-30 | $4.53M derived: sum of 2 quarters · filed 2015-03-26 | $4.67M derived: sum of 3 quarters · filed 2015-03-26 | $4.75M derived: sum of 4 quarters · filed 2015-03-26 | ||||
| 2012-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | $230.00K derived: sum of 2 quarters · filed 2015-03-26 | $312.00K derived: sum of 3 quarters · filed 2015-03-26 | $265.00K 10-K · filed 2015-03-26 | ||||
| 2012-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $229.00K derived: sum of 2 quarters · filed 2013-11-07 | $182.00K 10-Q · filed 2013-11-07 | $326.00K 10-Q · filed 2012-11-08 | $218.00K derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-06-30 | $82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $35.00K 10-Q · filed 2013-08-08 | $144.00K 10-Q · filed 2012-08-02 | $71.00K derived: sum of 3 quarters · filed 2014-03-11 | -$440.00K derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2012-03-31 | -$47.00K 10-Q · filed 2013-05-02 | -$38.00K 10-Q · filed 2012-05-03 | -$11.00K derived: sum of 2 quarters · filed 2014-03-11 | -$522.00K derived: sum of 3 quarters · filed 2014-03-11 | -$372.00K derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2011-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$475.00K derived: sum of 2 quarters · filed 2014-03-11 | -$325.00K derived: sum of 3 quarters · filed 2014-03-11 | -$201.00K 10-K · filed 2014-03-11 | -$412.00K 10-K · filed 2012-03-08 | |||
| 2011-09-30 | -$511.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$361.00K derived: sum of 2 quarters · filed 2012-11-08 | -$237.00K 10-Q · filed 2012-11-08 | -$3.10M derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-06-30 | $150.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $274.00K 10-Q · filed 2012-08-02 | -$2.59M derived: sum of 3 quarters · filed 2013-03-07 | $591.00K derived: sum of 4 quarters · filed 2013-03-07 | ||||
| 2011-03-31 | $124.00K 10-Q · filed 2012-05-03 | -$2.74M derived: sum of 2 quarters · filed 2013-03-07 | $441.00K derived: sum of 3 quarters · filed 2013-03-07 | |||||
| 2010-12-31 | -$2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $317.00K derived: sum of 2 quarters · filed 2013-03-07 | -$2.38M 10-K · filed 2013-03-07 | -$1.89M 10-K · filed 2012-03-08 | ||||
| 2010-09-30 | $3.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $486.00K 10-Q · filed 2011-11-03 | ||||||
| 2010-06-30 | -$2.70M 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | $2.96M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |